These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

2142 related items for PubMed ID: 28900864

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Catheter ablation for ventricular tachycardia in patients with an implantable cardioverter defibrillator (CALYPSO) pilot trial.
    Al-Khatib SM, Daubert JP, Anstrom KJ, Daoud EG, Gonzalez M, Saba S, Jackson KP, Reece T, Gu J, Pokorney SD, Granger CB, Hess PL, Mark DB, Stevenson WG.
    J Cardiovasc Electrophysiol; 2015 Feb; 26(2):151-7. PubMed ID: 25332150
    [Abstract] [Full Text] [Related]

  • 8. Substrate Ablation vs Antiarrhythmic Drug Therapy for Symptomatic Ventricular Tachycardia.
    Arenal Á, Ávila P, Jiménez-Candil J, Tercedor L, Calvo D, Arribas F, Fernández-Portales J, Merino JL, Hernández-Madrid A, Fernández-Avilés FJ, Berruezo A.
    J Am Coll Cardiol; 2022 Apr 19; 79(15):1441-1453. PubMed ID: 35422240
    [Abstract] [Full Text] [Related]

  • 9. A randomized clinical trial of catheter ablation and antiarrhythmic drug therapy for suppression of ventricular tachycardia in ischemic cardiomyopathy: The VANISH2 trial.
    Sapp JL, Tang ASL, Parkash R, Stevenson WG, Healey JS, Wells G.
    Am Heart J; 2024 Aug 19; 274():1-10. PubMed ID: 38649085
    [Abstract] [Full Text] [Related]

  • 10. Comparative effectiveness of antiarrhythmic drugs and catheter ablation for the prevention of recurrent ventricular tachycardia in patients with implantable cardioverter-defibrillators: A systematic review and meta-analysis of randomized controlled trials.
    Santangeli P, Muser D, Maeda S, Filtz A, Zado ES, Frankel DS, Dixit S, Epstein AE, Callans DJ, Marchlinski FE.
    Heart Rhythm; 2016 Jul 19; 13(7):1552-9. PubMed ID: 26961297
    [Abstract] [Full Text] [Related]

  • 11. Ranolazine reduces ventricular tachycardia burden and ICD shocks in patients with drug-refractory ICD shocks.
    Bunch TJ, Mahapatra S, Murdock D, Molden J, Weiss JP, May HT, Bair TL, Mader KM, Crandall BG, Day JD, Osborn JS, Muhlestein JB, Lappe DL, Anderson JL.
    Pacing Clin Electrophysiol; 2011 Dec 19; 34(12):1600-6. PubMed ID: 21895727
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Ventricular tachycardia characteristics and outcomes with catheter ablation vs. antiarrhythmic therapy: insights from the VANISH trial.
    Deyell MW, Doucette S, Parkash R, Nault I, Gula L, Gray C, Gardner M, Sterns LD, Healey JS, Essebag V, Sapp JL.
    Europace; 2022 Jul 21; 24(7):1112-1118. PubMed ID: 35030257
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Prognostic Value of Noninducibility on Outcomes of Ventricular Tachycardia Ablation: A VANISH Substudy.
    Essebag V, Joza J, Nery PB, Doucette S, Nault I, Rivard L, Gula L, Deyell M, Raymond JM, Lane C, Sapp JL.
    JACC Clin Electrophysiol; 2018 Jul 21; 4(7):911-919. PubMed ID: 30025692
    [Abstract] [Full Text] [Related]

  • 17. Arrhythmogenic right ventricular cardiomyopathy. Antiarrhythmic drugs, catheter ablation, or ICD?
    Wichter T, Paul TM, Eckardt L, Gerdes P, Kirchhof P, Böcker D, Breithardt G.
    Herz; 2005 Mar 21; 30(2):91-101. PubMed ID: 15875097
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Catheter ablation of stable ventricular tachycardia before defibrillator implantation in patients with coronary heart disease (VTACH): a multicentre randomised controlled trial.
    Kuck KH, Schaumann A, Eckardt L, Willems S, Ventura R, Delacrétaz E, Pitschner HF, Kautzner J, Schumacher B, Hansen PS, VTACH study group.
    Lancet; 2010 Jan 02; 375(9708):31-40. PubMed ID: 20109864
    [Abstract] [Full Text] [Related]

  • 20. Prevention of Recurrent Ventricular Tachycardia in Patients With Implantable Cardioverter Defibrillators-A Network Meta-analysis.
    Malik AH, Aronow WS.
    Am J Ther; 2019 Jan 02; 26(4):e469-e480. PubMed ID: 30946044
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 108.